1. Home
  2. Labeler Index
  3. Humacyte Global, Inc.
  4. 83564-110
  5. NDC Package Code: 83564-110-00 Symvess

NDC Package 83564-110-00 Symvess

Acellular Tissue Engineered Vessel Implant Intravascular - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
83564-110-00
Package Description:
1 BOX in 1 BAG / 1 IMPLANT in 1 BOX (83564-110-01)
Product Code:
83564-110
Proprietary Name:
Symvess
Non-Proprietary Name:
Acellular Tissue Engineered Vessel
Substance Name:
Acellular Tissue Engineered Vessel
Usage Information:
SYMVESS™ is an acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible.
11-Digit NDC Billing Format:
83564011000
NDC to RxNorm Crosswalk:
  • RxCUI: 2700346 - acellular tissue engineered vessel-tyod Vascular Implant
  • RxCUI: 2700346 - acellular tissue engineered vessel-tyod 40 CM Drug Implant
  • RxCUI: 2700352 - Symvess Vascular Implant
  • RxCUI: 2700352 - acellular tissue engineered vessel-tyod 40 CM Drug Implant [Symvess]
  • RxCUI: 2700352 - Symvess (acellular tissue engineered vessel-tyod) Vascular Implant
Product Type:
Human Prescription Drug
Labeler Name:
Humacyte Global, Inc.
Dosage Form:
Implant - A material containing drug intended to be inserted securely of deeply in a living site for growth, slow release, or formation of an organic union.
Administration Route(s):
Intravascular - Administration within a vessel or vessels.
Active Ingredient(s):
ACELLULAR TISSUE ENGINEERED VESSEL 420 mm/1
Sample Package:
No
FDA Application Number:
BLA125812
Marketing Category:
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date:
12-19-2024
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 83564-110-00?

The NDC Packaged Code 83564-110-00 is assigned to a package of 1 box in 1 bag / 1 implant in 1 box (83564-110-01) of Symvess, a human prescription drug labeled by Humacyte Global, Inc.. The product's dosage form is implant and is administered via intravascular form.

Is NDC 83564-110 included in the NDC Directory?

Yes, Symvess with product code 83564-110 is active and included in the NDC Directory. The product was first marketed by Humacyte Global, Inc. on December 19, 2024 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 83564-110-00?

The 11-digit format is 83564011000. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-283564-110-005-4-283564-0110-00